Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience

CONCLUSION: The TCH protocol is an efficacious neoadjuvant chemotherapy regimen for locally advanced and oligometastatic breast cancer and is safe and well tolerated in this population.

Source: Indian Journal of Cancer - December 1, 2017 Category: Cancer & Oncology Authors: A Tiwari A Gogia SVS Deo NK Shukla S Mathur DN Sharma Source Type: research